Which is better PCV 13 or PCV 23?

Which is better PCV 13 or PCV 23?

Not quite. They both protect against pneumococcal bacteria. Prevnar 13 protects against 13 types of bacteria, and Pneumovax 23 protects against 23 types of bacteria. Prevnar 13 is given in the muscle (IM), while Pneumovax 23 can be given either in the muscle (IM) or under the skin (subcutaneously).

What is the difference between PCV 13 and PPSV23?

PPSV23 contains antigens from 23 common serotypes, while PCV13 contains antigens from 13 serotypes. Although both vaccines aim to induce immunity against the most common serotypes to cause clinical disease, there is substantial overlap in the antigens contained within each vaccine.

When do you give Prevnar 13 and Pneumovax 23?

Administer 1 dose of PCV13 at 65 years or older. This dose should be given at least 1 year after PPSV23. Administer 1 final dose of PPSV23 at 65 years or older. This dose should be given at least 1 year after PCV13 and at least 5 years after the most recent dose of PPSV23.

When can get Pneumovax 23 after Prevnar 13?

Administer a single dose of PPSV23 at least 8 weeks after PCV13 was received. If the adult is 65 years or older, their pneumococcal vaccinations are complete.

Is Prevnar 13 still recommended for adults?

PCV13 vaccination is no longer routinely recommended for all adults age >65 years. Instead, shared clinical decision-making for PCV13 use is recommended for persons age >65 years who do not have an immunocompromising condition, CSF leak, or cochlear implant and who have not previously received PCV13.

Which pneumonia vaccine is best for over 65?

If You’re 65 or Older, it’s Time to get Your Pneumococcal Shots

• All adults 65 and older need two pneumococcal shots: the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23).
• Some adults who are 19 to 64 will need two pneumococcal shots – both PCV13 and PPSV23.

Is PCV13 the same as Prevnar 13?

Prevnar 13 (PCV13) protects against sickness caused by a bacteria called Streptococcus pneumoniae, also known as pneumococcus. Prevnar 13 was developed for infants and children. The CDC recommends that infants and children younger than 2 years of age get Prevnar 13, but some adults should get it too.

Is PCV 13 still recommended?

PCV13 vaccination is no longer routinely recommended for all adults aged ≥65 years. Instead, shared clinical decision-making for PCV13 use is recommended for persons aged ≥65 years who do not have an immunocompromising condition, CSF leak, or cochlear implant and who have not previously received PCV13 (Table 1).